Since the receptor density in the early phase of osteogenic differentiation showed no difference between the pASC groups (OM vs. OM + BMP-2), pASCs do not seem to be able to express enough endogenous BMP-2 to activate p38 MAPK and Wnt to successfully induce osteogenic differentiation. This evidence concerns the gene BMP2 and ocular melanoma.